INSIDER
01Overview02Daily Brief03Live04Congress05Corporate Insiders06Government Money07Political Influence08Institutions09Washington Network10Follow the Power11Disclosure Clock12AI Investigator13Watchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
Data sources

Public disclosures only. Scores flag unusual patterns and are not evidence of wrongdoing. Not investment advice.

RH CHAIN…
OverviewDaily BriefLiveCongressCorporate InsidersGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
01Overview02Daily Brief03Live04Congress05Corporate Insiders06Government Money07Political Influence08Institutions09Washington Network10Follow the Power11Disclosure Clock12AI Investigator13Watchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
OverviewDaily BriefLiveCongressCorporate InsidersGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
Data sources
SEC FORM 412m ago
HOUSE PTR11m ago
SEC 13F11m ago
ROBINHOOD CHAIN11m ago
Public company

ANROAlto Neuroscience, Inc.

CIK 0001999480

EDGAR filingsOpen in network
Disclosed transactions23
Buys / sells0 / 3
Max Insider Score42
Connections9with evidence

ANRO · disclosed activity on price

Disclosed transactions

ScoreActorSecuritySideValueExecutedDisclosedLagSourceEvidence
17
SC
Smith Nicholas ConradPRESIDENT AND CFO
ANROAlto Neuroscience, Inc.
Option exercise
M—
55.0K sh
Oct 2, 2026Oct 5, 2026
traded Oct 2, 2026
+3dSEC FORM 4

Evidence

Verified connections

  • In industryevidence
    Pharmaceuticals, devices & health servicesSEC SIC 2834 · Pharmaceutical Preparations · Nov 4, 2026
  • ← Insider ofevidence
    Sanchez RamiroDirector · May 14, 2026
  • ← Insider ofevidence
    Hanley Jr. Michael ConickCHIEF OPERATING OFFICER · Feb 13, 2026
  • ← Insider ofevidence
    Smith Nicholas ConradCHIEF FINANCIAL OFFICER & CBO · Feb 13, 2026
20
SC
Smith Nicholas ConradPRESIDENT AND CFO
ANROAlto Neuroscience, Inc.
Option exercise
M
$128K
55.0K sh
Oct 2, 2026
Oct 5, 2026
traded Oct 2, 2026
+3d
SEC FORM 4

Evidence

42
SC
Smith Nicholas ConradPRESIDENT AND CFO
ANROAlto Neuroscience, Inc.
Open-market sale
SELL$2.95M
110.8K sh
Sep 29, 2026Oct 1, 2026
traded Sep 29, 2026
+2dSEC FORM 4

Evidence

20
SC
Smith Nicholas ConradPRESIDENT AND CFO
ANROAlto Neuroscience, Inc.
Option exercise
M$57K
24.1K sh
Sep 30, 2026Oct 1, 2026
traded Sep 30, 2026
+1dSEC FORM 4

Evidence

24
SC
Smith Nicholas ConradPRESIDENT AND CFO
ANROAlto Neuroscience, Inc.
Option exercise
M$133K
56.5K sh
Sep 29, 2026Oct 1, 2026
traded Sep 29, 2026
+2dSEC FORM 4

Evidence

24
SC
Smith Nicholas ConradPRESIDENT AND CFO
ANROAlto Neuroscience, Inc.
Option exercise
M$128K
54.4K sh
Sep 29, 2026Oct 1, 2026
traded Sep 29, 2026
+2dSEC FORM 4

Evidence

17
SC
Smith Nicholas ConradPRESIDENT AND CFO
ANROAlto Neuroscience, Inc.
Open-market sale
SELL$24K
886 sh
Sep 30, 2026Oct 1, 2026
traded Sep 30, 2026
+1dSEC FORM 4

Evidence

21
SC
Smith Nicholas ConradPRESIDENT AND CFO
ANROAlto Neuroscience, Inc.
Option exercise
M—
56.5K sh
Sep 29, 2026Oct 1, 2026
traded Sep 29, 2026
+2dSEC FORM 4

Evidence

9
SC
Smith Nicholas ConradPRESIDENT AND CFO
ANROAlto Neuroscience, Inc.
Option exercise
M—
54.4K sh
Sep 29, 2026Oct 1, 2026
traded Sep 29, 2026
+2dSEC FORM 4

Evidence

13
SC
Smith Nicholas ConradPRESIDENT AND CFO
ANROAlto Neuroscience, Inc.
Option exercise
M—
24.1K sh
Sep 30, 2026Oct 1, 2026
traded Sep 30, 2026
+1dSEC FORM 4

Evidence

31
SC
Smith Nicholas ConradPRESIDENT AND CFO
ANROAlto Neuroscience, Inc.
Open-market sale
SELL$597K
23.2K sh
Sep 30, 2026Oct 1, 2026
traded Sep 30, 2026
+1dSEC FORM 4

Evidence

24
EA
Etkin AmitDirector, PRESIDENT AND CEO
ANROAlto Neuroscience, Inc.
Gift
G—
400.0K sh
May 14, 2026May 15, 2026
traded May 14, 2026
+1dSEC FORM 4

Evidence

9
SR
Sanchez RamiroDirector
ANROAlto Neuroscience, Inc.
Grant or award
A—
11.0K sh
May 12, 2026May 14, 2026
traded May 12, 2026
+2dSEC FORM 4

Evidence

9
YG
York GwillDirector
ANROAlto Neuroscience, Inc.
Grant or award
A—
11.0K sh
May 12, 2026May 14, 2026
traded May 12, 2026
+2dSEC FORM 4

Evidence

9
MH
Manji HusseiniDirector
ANROAlto Neuroscience, Inc.
Grant or award
A—
11.0K sh
May 12, 2026May 14, 2026
traded May 12, 2026
+2dSEC FORM 4

Evidence

9
CN
Cox Christopher NixonDirector
ANROAlto Neuroscience, Inc.
Grant or award
A—
11.0K sh
May 12, 2026May 14, 2026
traded May 12, 2026
+2dSEC FORM 4

Evidence

9
SC
Smith Nicholas ConradCHIEF FINANCIAL OFFICER & CBO
ANROAlto Neuroscience, Inc.
Grant or award
A—
200.0K sh
Feb 11, 2026Feb 13, 2026
traded Feb 11, 2026
+2dSEC FORM 4

Evidence

9
SA
Savitz AdamCHIEF MEDICAL OFFICER
ANROAlto Neuroscience, Inc.
Grant or award
A—
124.0K sh
Feb 11, 2026Feb 13, 2026
traded Feb 11, 2026
+2dSEC FORM 4

Evidence

9
EA
Etkin AmitDirector, PRESIDENT AND CEO
ANROAlto Neuroscience, Inc.
Grant or award
A—
306.0K sh
Feb 11, 2026Feb 13, 2026
traded Feb 11, 2026
+2dSEC FORM 4

Evidence

9
HC
Hanley Jr. Michael ConickCHIEF OPERATING OFFICER
ANROAlto Neuroscience, Inc.
Grant or award
A—
131.0K sh
Feb 11, 2026Feb 13, 2026
traded Feb 11, 2026
+2dSEC FORM 4

Evidence

9
MH
Manji HusseiniDirector
ANROAlto Neuroscience, Inc.
Grant or award
A$50K
4,228 sh
Jan 2, 2026Jan 6, 2026
traded Jan 2, 2026
+4dSEC FORM 4

Evidence

12
CN
Cox Christopher NixonDirector
ANROAlto Neuroscience, Inc.
Grant or award
A$85K
7,189 sh
Jan 2, 2026Jan 6, 2026
traded Jan 2, 2026
+4dSEC FORM 4

Evidence

12
YG
York GwillDirector
ANROAlto Neuroscience, Inc.
Grant or award
A$62K
5,243 sh
Jan 2, 2026Jan 6, 2026
traded Jan 2, 2026
+4dSEC FORM 4

Evidence

  • ← Insider ofevidence
    Etkin AmitDirector, PRESIDENT AND CEO · Feb 13, 2026
  • ← Insider ofevidence
    Savitz AdamCHIEF MEDICAL OFFICER · Feb 13, 2026
  • ← Insider ofevidence
    York GwillDirector · Jan 6, 2026
  • ← Insider ofevidence
    Manji HusseiniDirector · Jan 6, 2026
  • ← Insider ofevidence
    Cox Christopher NixonDirector · Jan 6, 2026